drugset / Trial / NCT07550972
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
NaSingle-groupOpen-labelTreatment
Summary
A single-arm, single-center clinical trial evaluating efficacy (Phase #)
Timeline
- Start
- 2026-05-01
- Primary completion
- 2030-03-31
- Completion
- 2030-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lenvatinib | Small molecule | 8 mg | — |
| Comparator | Pertuzumab | Monoclonal antibody | 3 mg/kg | — |